Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Novel targets for antithrombotic drug discovery.

Nanda N, Phillips DR.

Blood Cells Mol Dis. 2006 Mar-Apr;36(2):228-31. Epub 2006 Feb 13. Review.

PMID:
16473533
2.

Platelet aggregation induces platelet aggregate stability via SLAM family receptor signaling.

Nanda N, Andre P, Bao M, Clauser K, Deguzman F, Howie D, Conley PB, Terhorst C, Phillips DR.

Blood. 2005 Nov 1;106(9):3028-34. Epub 2005 Jul 21.

3.

Platelet endothelial aggregation receptor 1 (PEAR1), a novel epidermal growth factor repeat-containing transmembrane receptor, participates in platelet contact-induced activation.

Nanda N, Bao M, Lin H, Clauser K, Komuves L, Quertermous T, Conley PB, Phillips DR, Hart MJ.

J Biol Chem. 2005 Jul 1;280(26):24680-9. Epub 2005 Apr 25.

4.

Mice lacking the SLAM family member CD84 display unaltered platelet function in hemostasis and thrombosis.

Hofmann S, Braun A, Pozgaj R, Morowski M, Vögtle T, Nieswandt B.

PLoS One. 2014 Dec 31;9(12):e115306. doi: 10.1371/journal.pone.0115306. eCollection 2014.

5.

Differential expression of SAP and EAT-2-binding leukocyte cell-surface molecules CD84, CD150 (SLAM), CD229 (Ly9) and CD244 (2B4).

Romero X, Benítez D, March S, Vilella R, Miralpeix M, Engel P.

Tissue Antigens. 2004 Aug;64(2):132-44.

PMID:
15245368
6.

Structure of CD84 provides insight into SLAM family function.

Yan Q, Malashkevich VN, Fedorov A, Fedorov E, Cao E, Lary JW, Cole JL, Nathenson SG, Almo SC.

Proc Natl Acad Sci U S A. 2007 Jun 19;104(25):10583-8. Epub 2007 Jun 11.

7.

A novel mechanism of sustained platelet αIIbβ3 activation via PEAR1.

Kauskot A, Di Michele M, Loyen S, Freson K, Verhamme P, Hoylaerts MF.

Blood. 2012 Apr 26;119(17):4056-65. doi: 10.1182/blood-2011-11-392787. Epub 2012 Feb 27.

8.

Distinct interactions of the X-linked lymphoproliferative syndrome gene product SAP with cytoplasmic domains of members of the CD2 receptor family.

Lewis J, Eiben LJ, Nelson DL, Cohen JI, Nichols KE, Ochs HD, Notarangelo LD, Duckett CS.

Clin Immunol. 2001 Jul;100(1):15-23.

PMID:
11414741
9.
10.

Molecular dissection of 2B4 signaling: implications for signal transduction by SLAM-related receptors.

Chen R, Relouzat F, Roncagalli R, Aoukaty A, Tan R, Latour S, Veillette A.

Mol Cell Biol. 2004 Jun;24(12):5144-56.

11.

Inhibition of the plasma SCUBE1, a novel platelet adhesive protein, protects mice against thrombosis.

Wu MY, Lin YC, Liao WJ, Tu CF, Chen MH, Roffler SR, Yang RB.

Arterioscler Thromb Vasc Biol. 2014 Jul;34(7):1390-8. doi: 10.1161/ATVBAHA.114.303779. Epub 2014 May 15.

12.

Identification and characterization of SF2000 and SF2001, two new members of the immune receptor SLAM/CD2 family.

Fraser CC, Howie D, Morra M, Qiu Y, Murphy C, Shen Q, Gutierrez-Ramos JC, Coyle A, Kingsbury GA, Terhorst C.

Immunogenetics. 2002 Feb;53(10-11):843-50. Epub 2002 Jan 23.

PMID:
11862385
13.

NK cell regulation by SLAM family receptors and SAP-related adapters.

Veillette A.

Immunol Rev. 2006 Dec;214:22-34. Review.

PMID:
17100873
14.

Bone morphogenetic proteins.

Chen D, Zhao M, Mundy GR.

Growth Factors. 2004 Dec;22(4):233-41. Review.

PMID:
15621726
15.

Signaling pathways of the F11 receptor (F11R; a.k.a. JAM-1, JAM-A) in human platelets: F11R dimerization, phosphorylation and complex formation with the integrin GPIIIa.

Sobocka MB, Sobocki T, Babinska A, Hartwig JH, Li M, Ehrlich YH, Kornecki E.

J Recept Signal Transduct Res. 2004 Feb;24(1-2):85-105.

PMID:
15344881
16.

New costimulatory families: signaling lymphocytic activation molecule in adaptive allergic responses.

Makani SS, Jen KY, Finn PW.

Curr Mol Med. 2008 Aug;8(5):359-64. Review.

PMID:
18691062
17.

NTB-A receptor crystal structure: insights into homophilic interactions in the signaling lymphocytic activation molecule receptor family.

Cao E, Ramagopal UA, Fedorov A, Fedorov E, Yan Q, Lary JW, Cole JL, Nathenson SG, Almo SC.

Immunity. 2006 Oct;25(4):559-70.

18.

Antagonism of the GPIIb/IIIa receptor with the nonpeptidic molecule BIBU52: inhibition of platelet aggregation in vitro and antithrombotic efficacy in vivo.

Guth BD, Seewaldt-Becker E, Himmelsbach F, Weisenberger H, Müller TH.

J Cardiovasc Pharmacol. 1997 Aug;30(2):261-72.

PMID:
9269956
19.

Mouse novel Ly9: a new member of the expanding CD150 (SLAM) family of leukocyte cell-surface receptors.

Tovar V, del Valle J, Zapater N, Martin M, Romero X, Pizcueta P, Bosch J, Terhorst C, Engel P.

Immunogenetics. 2002 Sep;54(6):394-402. Epub 2002 Jul 18.

PMID:
12242590
20.

Molecular dissection of the signaling and costimulatory functions of CD150 (SLAM): CD150/SAP binding and CD150-mediated costimulation.

Howie D, Simarro M, Sayos J, Guirado M, Sancho J, Terhorst C.

Blood. 2002 Feb 1;99(3):957-65.

Supplemental Content

Support Center